SCHEMBL4179006

SCHEMBL4179006

CC1(O)CC(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25992902 1.00
SCHEMBL13589461 0.82
SCHEMBL2352644 0.80
SCHEMBL14370535 0.78
SCHEMBL15692364 0.76
SCHEMBL21827458 0.76
SCHEMBL21827980 0.76
SCHEMBL22484527 0.76
SCHEMBL16666823 0.76
SCHEMBL16666820 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624033-B2 KRAS inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-12 US disclosed
EP-4735439-A1 KRAS INHIBITORS Bristol-Myers Squibb Company (US) 2026-05-06 EP disclosed
EP-4735440-A1 KRAS INHIBITORS Bristol-Myers Squibb Company (US) 2026-05-06 EP disclosed
US-20250304537-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2025-10-02 US disclosed
US-20250250271-A1 KRAS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2025-08-07 US disclosed
US-12331026-B2 Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors NIKANG THERAPEUTICS, INC. (US) 2025-06-17 US disclosed
EP-4554945-A1 PYRROLOTRIAZINE AND IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF THE NLRP3 INFLAMMASOME PATHWAY AC Immune SA (CH) 2025-05-21 EP disclosed
US-20250154148-A1 KRAS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2025-05-15 US disclosed
US-20250145599-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS MRJA THERAPEUTICS, INC. 2025-05-08 US disclosed
CN-119907802-A Pyrrolotriazine and imidazotriazine derivatives as modulators of NLRP3 inflammatory small body pathways AC免疫有限公司 2025-04-29 CN disclosed
US-20200108075-A1 8-AMINOISOQUINOLINE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2020-04-09 US disclosed
CN-107109040-B Polytrimethylene terephthalate composition, polyester fiber and its manufacturing method 帝人富瑞特株式会社 2019-06-28 CN disclosed
CN-109694470-A A kind of preparation method of high heat resistance amorphous polyester 中国石化仪征化纤有限责任公司 2019-04-30 CN disclosed
CN-109694468-A The preparation method of high heat resistance bottle modified poly ester 中国石化仪征化纤有限责任公司 2019-04-30 CN disclosed
WO-2019048541-A1 1-(4-(ISOXAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATING AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION IMMUNIC AG (DE) 2019-03-14 WO disclosed
US-20090023885-A1 TREATMENT METHOD FOR IMPARTING HIGH IMPACT RESISTANCE IN CERTAIN CBDO COPOLYMERS TEXAS STATE UNIVERSITY - SAN MARCOS (US) 2009-01-22 US disclosed
EP-1899401-A1 FILM(S)AND/OR SHEET(S) COMPRISING POLYESTER COMPOSITIONS WHICH COMPRISE CYCLOBUTANEDIOL AND HAVE A CERTAIN COMBINATION OF INHERENT VISCOSITY AND HIGH GLASS TRANSITION TEMPERATURE EASTMAN CHEMICAL COMPANY (US) 2008-03-19 EP disclosed
WO-2007001565-A1 FILM(S)AND/OR SHEET(S) COMPRISING POLYESTER COMPOSITIONS WHICH COMPRISE CYCLOBUTANEDIOL AND HAVE A CERTAIN COMBINATION OF INHERENT VISCOSITY AND HIGH GLASS TRANSITION TEMPERATURE EASTMAN CHEMICAL COMPANY (US) 2007-01-04 WO disclosed
WO-1995012640-A1 THERMOSETTING COATING COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 1995-05-11 WO disclosed
WO-1991004285-A1 NON-CRYSTALLINE ACETAL COPOLYMER ELASTOMERS HOECHST CELANESE CORP (US) 1991-04-04 WO disclosed